Clin2
NCT06723366Possibly a fitNot yet recruiting

Angong Niuhuang for brain protection after heart surgery

Cardio-pulmonary BypassCardiovascular SurgeryCerebral ProtectionBrain Injury

Part of Brain & nervous system, Injuries & trauma clinical trials.

This study tests a traditional Chinese medicine called Angong Niuhuang to see if it can reduce brain damage and improve recovery after heart surgery. If you've had a stroke or brain problem after your surgery, this treatment might help calm inflammation and protect your brain.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • You must have had heart or blood vessel surgery.
  • You must have had a stroke or similar brain problem after your surgery (like a blocked artery in the brain).
  • Your brain symptoms must be considered moderate (measured by a standard stroke scale score between 10 and 20).
  • Your symptoms must have started within the last 36 hours.
  • You must not have liver failure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07200921Not yet recruiting· Phase 2
Treatment for brain bleed caused by high blood pressure using Naoxuekang pills

This trial tests whether an oral traditional Chinese medicine called Naoxuekang dropping pills, given in addition to standard care, can reduce the long-term disability caused by a brain bleed due to high blood pressure. It may help improve recovery for people who have had a recent brain bleed and show signs of small vessel disease on an MRI.

Beijing, Beijing Municipality
NCT07445581Not yet recruiting
Herbal medicine for elderly heart attack patients with brain artery narrowing

This study tests a traditional Chinese herbal medicine, Tanhuo Decoction, in elderly patients who have had a recent heart attack and also have narrowed brain arteries. It aims to see if adding this herbal treatment to standard care helps improve their recovery.

Beijing, Beijing Municipality
NCT07250035Recruiting· Phase 3
Chinese herb trial for brain bleed linked to amyloid angiopathy

This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.

Beijing
NCT06845254Not yet recruiting· Phase 3
Xuesaitong capsules for heart patients after stent procedure

This study tests a Chinese herbal medicine called Xuesaitong soft capsules for people who recently had a heart attack or unstable angina and had a stent placed. The goal is to see if taking these capsules helps improve heart health after the procedure.

Beijing
NCT07617675Not yet recruiting· Phase 4
Study of a heart medication to prevent kidney injury after heart surgery

This study tests whether giving a medication called rhBNP during heart surgery can help protect your kidneys from injury. It may reduce the chance of kidney problems after the operation.

Beijing
NCT07074938Recruiting
Traditional Chinese medicine for brain injury recovery

This trial tests whether a traditional Chinese medicine called An Gong Niuhuang Wan can help people recover brain function after a traumatic brain injury and surgery. It may be a good fit if you are moderately affected (GCS 6–12) and your condition is stable enough to start treatment within three days.

Wuhan, Hubei

Hear when a new Cardio-pulmonary Bypass trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.